openPR Logo
Press release

Global Biosimilars Market Research Report

04-22-2019 07:30 PM CET | Health & Medicine

Press release from: Market Density

This report studies the global Biosimilars market status and forecast, categorizes the global Biosimilars market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report Pfizer Sandoz International GmbH Teva Pharmaceuticals Industries Amgen Inc Biocon Dr. Reddy’s Laboratories F. Hoffmann-La Roche Celltrion Samsung Bioepis Geographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering North America Europe China Japan Southeast Asia India We can also provide the customized separate regional or country-level reports, for the following regions: North America United States Canada Mexico Asia-Pacific China India Japan South Korea Australia Indonesia Singapore Rest of Asia-Pacific Europe Germany France UK Italy Spain Russia Rest of Europe Central & South America Brazil Argentina Rest of South America Middle East & Africa Saudi Arabia Turkey Rest of Middle East & Africa On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon) Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin) Peptides (Glucagon, Calcitonin) On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including Oncology Blood Disorders The study objectives of this report are: To analyze and study the global Biosimilars capacity, production, value, consumption, status (2013-2017) and forecast (2018-2025); Focuses on the key Biosimilars manufacturers, to study the capacity, production, value, market share and development plans in future. Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis. To define, describe and forecast the market by type, application and region. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks. To identify significant trends and factors driving or inhibiting the market growth. To analyze the opportunities in the market for stakeholders by identifying the high growth segments. To strategically analyze each submarket with respect to individual growth trend and their contribution to the market To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market To strategically profile the key players and comprehensively analyze their growth strategies. In this study, the years considered to estimate the market size of Biosimilars are as follows: History Year: 2013-2017 Base Year: 2017 Estimated Year: 2018 Forecast Year 2018 to 2025 For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered. Key Stakeholders Biosimilars Manufacturers Biosimilars Distributors/Traders/Wholesalers Biosimilars Subcomponent Manufacturers Industry Association Downstream Vendors Available Customizations With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report: Regional and country-level analysis of the Biosimilars market, by end-use. Detailed analysis and profiles of additional market players.

Get sample copy of the report:

https://www.marketdensity.com/contact?ref=Sample&reportid=120807

Table of Contents:

Table of Contents

Global Biosimilars Market Research Report 2018
1 Biosimilars Market Overview
1.1 Product Overview and Scope of Biosimilars
1.2 Biosimilars Segment by Type (Product Category)
1.2.1 Global Biosimilars Production and CAGR (%) Comparison by Type (Product Category)(2013-2025)
1.2.2 Global Biosimilars Production Market Share by Type (Product Category) in 2017
1.2.3 Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon)
1.2.3 Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin)
Peptides (Glucagon, Calcitonin)
1.3 Global Biosimilars Segment by Application
1.3.1 Biosimilars Consumption (Sales) Comparison by Application (2013-2025)
1.3.2 Oncology
1.3.3 Blood Disorders
1.4 Global Biosimilars Market by Region (2013-2025)
1.4.1 Global Biosimilars Market Size (Value) and CAGR (%) Comparison by Region (2013-2025)
1.4.2 North America Status and Prospect (2013-2025)
1.4.3 Europe Status and Prospect (2013-2025)
1.4.4 China Status and Prospect (2013-2025)
1.4.5 Japan Status and Prospect (2013-2025)
1.4.6 Southeast Asia Status and Prospect (2013-2025)
1.4.7 India Status and Prospect (2013-2025)
1.5 Global Market Size (Value) of Biosimilars (2013-2025)
1.5.1 Global Biosimilars Revenue Status and Outlook (2013-2025)
1.5.2 Global Biosimilars Capacity, Production Status and Outlook (2013-2025)

2 Global Biosimilars Market Competition by Manufacturers
2.1 Global Biosimilars Capacity, Production and Share by Manufacturers (2013-2018)
2.1.1 Global Biosimilars Capacity and Share by Manufacturers (2013-2018)
2.1.2 Global Biosimilars Production and Share by Manufacturers (2013-2018)
2.2 Global Biosimilars Revenue and Share by Manufacturers (2013-2018)
2.3 Global Biosimilars Average Price by Manufacturers (2013-2018)
2.4 Manufacturers Biosimilars Manufacturing Base Distribution, Sales Area and Product Type
2.5 Biosimilars Market Competitive Situation and Trends
2.5.1 Biosimilars Market Concentration Rate
2.5.2 Biosimilars Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Biosimilars Capacity, Production, Revenue (Value) by Region (2013-2018)
3.1 Global Biosimilars Capacity and Market Share by Region (2013-2018)
3.2 Global Biosimilars Production and Market Share by Region (2013-2018)
3.3 Global Biosimilars Revenue (Value) and Market Share by Region (2013-2018)
3.4 Global Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.5 North America Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.6 Europe Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.7 China Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.8 Japan Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.9 Southeast Asia Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.10 India Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

4 Global Biosimilars Supply (Production), Consumption, Export, Import by Region (2013-2018)
4.1 Global Biosimilars Consumption by Region (2013-2018)
4.2 North America Biosimilars Production, Consumption, Export, Import (2013-2018)
4.3 Europe Biosimilars Production, Consumption, Export, Import (2013-2018)
4.4 China Biosimilars Production, Consumption, Export, Import (2013-2018)
4.5 Japan Biosimilars Production, Consumption, Export, Import (2013-2018)
4.6 Southeast Asia Biosimilars Production, Consumption, Export, Import (2013-2018)
4.7 India Biosimilars Production, Consumption, Export, Import (2013-2018)

5 Global Biosimilars Production, Revenue (Value), Price Trend by Type
5.1 Global Biosimilars Production and Market Share by Type (2013-2018)
5.2 Global Biosimilars Revenue and Market Share by Type (2013-2018)
5.3 Global Biosimilars Price by Type (2013-2018)
5.4 Global Biosimilars Production Growth by Type (2013-2018)

6 Global Biosimilars Market Analysis by Application
6.1 Global Biosimilars Consumption and Market Share by Application (2013-2018)
6.2 Global Biosimilars Consumption Growth Rate by Application (2013-2018)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries

7 Global Biosimilars Manufacturers Profiles/Analysis
7.1 Pfizer
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Biosimilars Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 Pfizer Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.1.4 Main Business/Business Overview
7.2 Sandoz International GmbH
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Biosimilars Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 Sandoz International GmbH Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.2.4 Main Business/Business Overview
7.3 Teva Pharmaceuticals Industries
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.3.2 Biosimilars Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 Teva Pharmaceuticals Industries Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.3.4 Main Business/Business Overview
7.4 Amgen Inc
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.4.2 Biosimilars Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 Amgen Inc Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.4.4 Main Business/Business Overview
7.5 Biocon
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.5.2 Biosimilars Product Category, Application and Specification
7.5.2.1 Product A
7.5.2.2 Product B
7.5.3 Biocon Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2015-2018)
7.5.4 Main Business/Business Overview
7.6 Dr. Reddy’s Laboratories
7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.6.2 Biosimilars Product Category, Application and Specification
7.6.2.1 Product A
7.6.2.2 Product B
7.6.3 Dr. Reddy’s Laboratories Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.6.4 Main Business/Business Overview
7.7 F. Hoffmann-La Roche
7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.7.2 Biosimilars Product Category, Application and Specification
7.7.2.1 Product A
7.7.2.2 Product B
7.7.3 F. Hoffmann-La Roche Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.7.4 Main Business/Business Overview
7.8 Celltrion
7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.8.2 Biosimilars Product Category, Application and Specification
7.8.2.1 Product A
7.8.2.2 Product B
7.8.3 Celltrion Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.8.4 Main Business/Business Overview
7.9 Samsung Bioepis
7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.9.2 Biosimilars Product Category, Application and Specification
7.9.2.1 Product A
7.9.2.2 Product B
7.9.3 Samsung Bioepis Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.9.4 Main Business/Business Overview

8 Biosimilars Manufacturing Cost Analysis
8.1 Biosimilars Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Biosimilars

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Biosimilars Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Biosimilars Major Manufacturers in 2017
9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List

11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 Global Biosimilars Market Forecast (2018-2025)
12.1 Global Biosimilars Capacity, Production, Revenue Forecast (2018-2025)
12.1.1 Global Biosimilars Capacity, Production and Growth Rate Forecast (2018-2025)
12.1.2 Global Biosimilars Revenue and Growth Rate Forecast (2018-2025)
12.1.3 Global Biosimilars Price and Trend Forecast (2018-2025)
12.2 Global Biosimilars Production, Consumption , Import and Export Forecast by Region (2018-2025)
12.2.1 North America Biosimilars Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.2 Europe Biosimilars Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.3 China Biosimilars Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.4 Japan Biosimilars Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.5 Southeast Asia Biosimilars Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.6 India Biosimilars Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.3 Global Biosimilars Production, Revenue and Price Forecast by Type (2018-2025)
12.4 Global Biosimilars Consumption Forecast by Application (2018-2025)

13 Research Findings and Conclusion

14 Appendix
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer
Browse this report online:

https://www.marketdensity.com/global-biosimilars-market-research-report

About Market Density:

Market Density is your one stop market research and industry analysis reports' library providing business data and intelligence information on thousands of micro markets with global as well as regional coverage.
Market Density offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.
Market Density understands how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.
Contact Us:

Email: sales@marketdensity.com

Website: www.marketdensity.com

Phone: +1 669 264 1656

4340 Stevens Creek Blvd,, Suite # 172,, San Jose, CA 95129

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Biosimilars Market Research Report here

News-ID: 1713087 • Views: 551

More Releases from Market Density

Global Product Management Software Market Size, Status and Forecast
This report focuses on the global Product Management Software status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Product Management Software development in United States, Europe and China. In 2017, the global Product Management Software market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2018-2025. The key players
Global Computer Aided Engineering (CAE) Market Size, Status and Forecast
This report focuses on the global Computer Aided Engineering (CAE) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Computer Aided Engineering (CAE) development in United States, Europe and China. Computer-aided engineering is the broad usage of computer software to aid in engineering analysis tasks. In regard to information networks, CAE systems are individually considered a single node on a total information
Global Computerized Numerical Control Market Size, Status and Forecast
This report focuses on the global Computerized Numerical Control status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Computerized Numerical Control development in United States, Europe and China. Computer numerical control (CNC) is the automation of machine tools by means of computers executing pre-programmed sequences of machine control commands. The key factor contributing to the computerized numerical control market is the growth
Global Connected Retail Market Size, Status and Forecast
This report focuses on the global Connected Retail status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Connected Retail development in United States, Europe and China. A Connected Retail strategy allows people to use the strength of the network to connect the brands to today's consumers. Connected Retail can help collaborate more effectively with employees and field managers, maintain security vigilance and

All 5 Releases


More Releases for Biosimilars

PHASE-XS – Access To Life Changing Biosimilars
Biopharmaceutical is one of the fastest growing industries with addition of numerous biologics that provide novel treatment modalities for life-threatening and rare diseases. Biologics are produced from living organisms through unique manufacturing and purification processes. It includes a wide variety of products such as vaccines, blood, blood components, cells, allergens, genes, tissues, and recombinant proteins that are derived from human, animal or microorganisms by using biotechnological procedures. Some examples for
Insulin Biosimilars Market, by Biosimilar Type Rapid-acting Biosimilars, Long-ac …
Diabetes is a group of metabolic disease characterized by high blood sugar level due to inadequate secretion of insulin. Common symptoms of diabetes include increased hunger, tiredness, weight loss, and excessive thirst and urination. The prevalence of diabetes is increasing, in turn, boosting demand for insulin biosimilar. For instance, according the World Health Organization (WHO) report in 2014, globally around 422 million adults were living with diabetes and 1.5 million
Insulin Biosimilars Market, by Biosimilar Type Rapid-acting Biosimilars, Long-ac …
Biosimilar is a medicine developed on the original biological reference product. The production process of biopharmaceuticals vary from one manufacturer to another, thus every biosimilar product is unique from the other. Biosimilar manufactures use different culture conditions, master cell lines, purification techniques, and raw materials. This in turn, helps meet the rising prevalence of diabetes due to inadequate healthcare services, rising prevalence of obesity, For instance, According to 2013 American
Humira Biosimilars Clinical Trial Insight
“Humira Biosimilars Clinical Trial Insight” report by PNS Pharma gives comprehensive clinical insight on 33 biosimilars version of Humira drug in clinical pipeline. More than 10 of these biosimilars are in Phase-III trials and are expected to be commercially available in next 5-8 years. The patent protection assigned to Humira will expire in 2016 for US and 2018 for European market.
Enbrel Biosimilars Clinical Trial Insight
“Enbrel Biosimilars Clinical Trial Insight” report by PNS Pharma gives comprehensive clinical insight on 36 biosimilars version of Enbrel drug in clinical pipeline. More than 5 of these biosimilars are in Phase-III trials and are expected to be commercially available in next 5-8 years. Currently 5 biosimilar version of Enbrel are commercially available in Iran, Mexico, India, UK and Australia. The patent on Enbrel was originally set to expire on
Europe Biosimilars Market & Pipeline Insight
Biosimilars have emerged as one of the most promising segment of the European pharmaceutical industry in recent years. The biosimilars segment has been experiencing a steady growth driven by patent expiration of blockbuster drugs, amenable regulatory framework, economic incentives along with favorable pricing and reimbursement policies adopted across multiple markets in Europe. The current biosimilars market is highly fragmented in nature due to their accessibility in various therapeutic categories. The